Skip to main content

Odyssey Health, Inc.

For the period ended Oct 31, 2025. Filed Dec 11, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Oct 31, 2025 · Filed Dec 11, 2025

ODYYStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Changes in Stockholders’ Deficit

Common Stock · Additional Paid-In · Accumulated · Total Shareholders’
SharesDollarsCapitalDeficit(Deficit)
Balances, July 31, 202596,709,763$96,710$55,694,429$(62,745,837)$(6,954,698)
Common stock issued for conversion of accrued interest and fees1,144,0001,14481,224–82,368
Common stock issued for conversion of outstanding principal2,000,0002,000142,000–144,000
Warrants issued in debt financing––56,589–56,589
Net loss–––(483,447)(483,447)
Balances, October 31, 202599,853,763$99,854$55,974,242$(63,229,284)$(7,155,188)
Common Stock · Additional Paid-In · Accumulated · Total Shareholders’
SharesDollarsCapitalDeficit(Deficit)
Balances, July 31, 202496,709,763$96,710$55,572,687$(61,003,146)$(5,333,749)
Stock-based compensation––60,487–60,487
Warrants issued in debt financing––13,343–13,343
Net loss–––(1,018,906)(1,018,906)
Balances, October 31, 202496,709,763$96,710$55,646,517$(62,022,052)$(6,278,825)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.